Rationale: Fluid shear stress differentially regulates endothelial cell stress fiber formation with decreased stress fibers in areas of disturbed flow compared with steady flow areas. Importantly, stress fibers are critical for several endothelial cell functions including cell shape, mechano-signal transduction, and endothelial cell-cell junction integrity. A key mediator of steady flow-induced stress fiber formation is Src that regulates downstream signaling mediators such as phosphorylation of cortactin, activity of focal adhesion kinase, and small GTPases.
A lthough not fully understood, the mechanism by which blood flow transduces a signal into endothelial cells (EC) is dependent on the frictional force generated by blood flow, known as fluid shear stress (FSS). Changes in blood flow patterns are a well-established regulator of EC morphology, function, and homeostasis. Specifically, regions that are exposed to steady blood flow (s-flow; eg, the greater curvature of the aortic arch) are known to be atherosclerosis protected, whereas disturbed blood flow regions (d-flow; eg, the lesser curvature of the aortic arch or flow divider regions) are atherosclerosis prone. [1] [2] [3] Physiologically, s-flow regions are characterized by unidirectional high FSS force (>10 dyn/cm 2 ), whereas d-flow regions are characterized by nonunidirectional, nonsteady flow patterns, and low shear stress force (<5 dyn/cm 2 ). [4] [5] [6] Mechanistically, s-flow regions are atherosclerosis protected mainly because of increases in anti-inflammatory and antioxidative stress protein expression, including Kruppel-like factor 2, endothelial nitric oxide synthase, thioredoxin, and unidirectional stress fiber formation. [7] [8] [9] In contrast, d-flow regions are atherosclerosis prone because of endothelial dysfunction that is characterized by an inhibition of anti-inflammatory factors, increased expression of adhesion molecules, increase in reactive oxygen species generation, and reduced stress fibers number. [10] [11] [12] As a result of EC dysfunction, circulating free leukocytes are recruited to and bind at the site of injury, transmigrate through the endothelium, and induce chronic inflammation to promote atherogenesis. Importantly, FSS regulates the activation of multiple plasma membrane (PM) tyrosine kinase receptors, including vascular endothelial growth factor (VEGF) receptor 2, Tie1, and platelet-derived growth factor receptor. Consequently, Src family kinases are activated, promoting phosphorylation of PM scaffolds such as platelet EC adhesion molecule 1 and vascular endothelial cadherin (VE-cadherin). [13] [14] [15] [16] [17] These pathways are important for multiple endothelial functions, such as vasodilation, inflammation, angiogenesis, and migration. Many of these events require formation and remodeling of stress fibers that are specialized actin structures in EC. [18] [19] [20] In particular, VE-cadherin is a transmembrane receptor that acts as a FSS-sensing molecule to regulate endothelial stress fiber formation by 2 mechanisms: first, by increased phosphorylation and transduction of extracellular signals into the cytoplasm; and second, by acting as a docking site for adapter proteins and phosphatases. 21, 22 VE-cadherin interacts with Src homology phosphatase-2 (SHP2) and Src to regulate EC stress fiber formation. 23, 24 For example, in response to VEGF, the endothelial receptor VEGF receptor 2 is activated, leading to 3 consequent steps: recruitment of SHP2 to the VE-cadherin complex followed by activation of Src kinase protein and changes in stress fiber dynamics. 25, 26 We recently showed that thioredoxin-interacting protein (TXNIP) is highly regulated by changes in blood flow. In d-flow regions, TXNIP is highly induced and promotes endothelial inflammation and apoptosis, whereas in s-flow regions, TXNIP expression is suppressed. 27 Furthermore, TXNIP is an α-arrestin protein, which has an important function in cellular signaling, acting as a scaffold protein, to regulate formation of signaling complexes and subcellular-specific signaling events. [28] [29] [30] [31] Specifically, TXNIP is important for activation of VEGF receptor 2 at the PM and downstream signaling, which is important for Src activation. 13 Based on our recent TXNIP structure-function analyses, 32 we propose that in response to FSS, TXNIP regulates Src activation via regulation of VE-cadherin-SHP2-Src complex, resulting in altered EC stress fibers.
Methods

Animals
All animal experiments were conducted in accordance with experimental protocols that were approved by the University Committee on Animal Resources of the University of Rochester. Animals were maintained under pathogen-free conditions at the Aab Cardiovascular Research Institute of the University of Rochester.
En Face Staining
Immunofluorescence staining of mouse aortic EC was performed using 24-week-old control or TXNIP-knockout mice. Mice were anesthetized with ketamine/xylazine cocktail (0.13/0.0088 mg/g body weight), the jugular vein was cut, and the arterial tree was perfused with saline containing 40 USPU [United States pharmacopeia unit]/mL heparin from left ventricle for 5 minutes, followed by perfusion of prechilled 4% paraformaldehyde in PBS (pH 7.4) for 10 minutes. Subsequently, the whole aorta was dissected from iliac bifurcation to the heart, cut open longitudinally, permeabilized with 0.1% Triton X-100 in PBS for 10 minutes, and blocked with 10% normal goat serum in Tris-buffered saline containing 2.5% Tween-20 for 1 hour at room temperature. Next, aortas were incubated with primary antibody in blocking buffer overnight at 4°C. After rinsing with washing solution (Tris-buffered saline containing 2.5% Tween-20) 3×, fluorescence-conjugated secondary antibodies were applied for 1 hour at room temperature. Finally, after another 3 rinses in the washing solution, aortas were mounted in the ProLong antifade reagent (Invitrogen, Eugene, OR). Aortas were examined by a laser-scanning confocal microscope (FV-1000 mounted on IX81, Olympus) with UPlanSApo ×20 or UPlanFL N ×40 lens.
Cell Culture, Western Blot, and Small Interfering RNA Transfection
Human umbilical vein EC (HUVEC) or bovine aortic EC were grown and transfected with plasmid/small interfering RNA (siRNA) as detailed in the online-only Data Supplement and previously described. 33 
In Vitro Flow Experiments
To perform biochemical studies, we used a cone-and-plate flow apparatus, and HUVEC cultured in 60-mm dishes were exposed to s-flow at 12 dyn/cm 2 by using smooth cones (120 rpm) or exposed to d-flow at 2 dyn/cm 2 by using grooved cones (5 rpm) for 24 hours. The shear stress imposed on the surface of the plate was calculated by the formula ωμ/θ where ω is the rotation speed, μ is the fluid viscosity, and θ is the angle of the cone.
Immunofluorescence
Treated HUVEC in 35-mm dishes were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 15 minutes, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes, and blocked with 10% normal goat serum in PBS containing 0.5% Tween-20 for 1 hour at room temperature. Then cells were stained with primary antibodies overnight at 4°C in blocking solution. Cells were then rinsed with 0.5% Tween-20 in PBS 3× and incubated with the fluorescence-conjugated secondary antibodies for 1 hour at room temperature. After another 3 rinses with the washing solution, images were acquired using an inverted epifluorescence microscope (IX50, Olympus) equipped with a charge-coupled device camera (Spot; Diagnostic Instruments, Inc) with Cropland water ×40 (numerical aperture, 0.8) or ×60 (numerical aperture, 0.9) objective lens or laser-scanning confocal microscope (FV-1000 mounted on IX81, Olympus) with UPlanSApo ×20 or UPlanFL N ×40 lens.
Statistical Analysis
Group differences were analyzed using the standard Student t test. All values are expressed as mean±SE. P<0.05 was considered statistically significant.
Results
TXNIP Regulates Src Phosphorylation In Vivo
To evaluate the role of TXNIP in Src phosphorylation in vivo, we measured the phosphorylation state of tyrosine 416 (Y416) and tyrosine 527 (Y527) using en face staining of EC lining the aorta. Under basal conditions, Src Y527 is phosphorylated (phospho-tyrosine 527 [pY527]), which maintains low kinase activity. In response to many stimuli, Src pY527 is dephosphorylated, which induces a conformational change in the activation loop. Full kinase activation then occurs by phosphorylation of Src Y416 (phospho-tyrosine 416 [pY416]). 34 To demonstrate an endothelial role of TXNIP in differential phosphorylation states of Y416 and Y527 of Src, we used TXNIP-knockout mice. In the aorta exposed to s-flow, control animals exhibited low levels of phospho-Y416 (pY416) and high levels of pY527 ( Figure 1A -1C, 1H-1J). In contrast, the aorta of knockout animals showed a dramatic increase in Src pY416 and decrease in pY527 ( Figure 1D -1G, 1K-1N). To confirm these findings, we also scanned sites where the spinal arteries branch from the aorta; these sites are characterized by both s-and d-flow regions. There was a clear increase in Src pY416 and decrease in pY527 as shown in Online Figure I . Total Src expression was not significantly different between these animals (Online Figure II and III), suggesting that the effect observed was because of TXNIP's effect on a Src regulatory mechanism.
Src Phosphorylation State of Tyrosine 416 and 527 Is Differentially Regulated by TXNIP In Vitro
To confirm this observation in vitro, we measured Src pY416 and pY527 in cultured HUVEC exposed to s-flow or d-flow. Shown in Figure 2 , TXNIP expression is reduced under s-flow conditions, whereas it is dramatically increased under d-flow conditions. In addition, Y416 is highly phosphorylated under s-flow conditions and dephosphorylated under d-flow conditions ( Figure 2 ). Finally, Y527 phosphorylation level was low under s-flow conditions but highly phosphorylated under d-flow conditions ( Figure 2 ). This observation was also confirmed by an immunofluorescence experiment using HUVEC exposed to s-flow or d-flow (Online Figure IV) .
In addition, we also measured pY416 and pY527 in HUVEC in which TXNIP was depleted using siRNA. HUVEC transfected with control siRNA had low levels of pY416 and high levels of pY527, whereas TXNIP siRNAtransfected cells had a 2.5-fold increase in pY416 and a 0.7-fold decrease in pY527 (Online Figure V ). Furthermore, we confirmed this differential phosphorylation state of Y416 and Y527 using an immunofluorescence approach to measure pY416 and pY527 in cultured HUVEC in which TXNIP was depleted using siRNA. In HUVEC transfected with control siRNA, low levels of pY416 were observed, whereas in TXNIP siRNA-transfected cells, a 2.5-fold increase in pY416 was observed (Online Figure VIA-VIF and VIM). Increased pY416 was at the PM and diffusely in the cytosol. The results obtained for pY527 were opposite for those observed with pY416, as expected. In control siRNA-transfected cells, high levels of pY527 were observed, whereas in TXNIP siRNA-transfected cells, there was a significant 60% decrease in pY527 ( Figure VIG-VIL and VIN) . To confirm these results, we also used confocal microscopy as shown in Online Figure VII . All together, our in vivo and in vitro data strongly suggest that TXNIP acts as an endogenous inhibitor of Src activation in EC.
TXNIP Prevents SHP2 Phosphatase Interaction With VE-Cadherin
Next, we hypothesized that TXNIP prevents SHP2 to be recruited to VE-cadherin. Previously, it was shown that SHP2 dephosphorylates C-terminal Src kinase (CSK), which is important inhibitor of Src via phosphorylation of the inhibitory Y527. 25 Inhibition of CSK allows relief of the inhibitory effect of pY527 and activation of Src. SHP2 activity is regulated in EC through an interaction with VE-cadherin that acts as a docking site for a complex of proteins including Src, CSK, and SHP2. 25 Because TXNIP is an α-arrestin protein and contains several protein-protein binding motifs 29 (eg, PPxY [proline, proline, any amino acid, tyrosine] motif or ITIM [immunoreceptor tyrosine-based inhibition] motif), we hypothesized that TXNIP prevents SHP2 from interacting with VE-cadherin. To test this hypothesis, we measured VEcadherin-SHP2 interaction (Figure 3 ) in cells transfected with TXNIP or control siRNA. In addition, we cotransfected these cells with 2 different plasmids: TXNIP wild type (TX-WT) or TXNIP mutant Y378A (Y378A). Tyrosine 378 (Y378) is part of an identified PPxY motif within the arrestin domain of TXNIP. Based on an extensive mutagenesis analysis, we discovered that Y378A fails to interact with SHP2 ( Figure 3A) . To test the hypothesis that TXNIP regulates SHP2 ability to interact with VE-cadherin, we introduced 2 green fluorescent protein (GFP)-tagged plasmids TX-WT-GFP or Y378A-GFP and measured VE-cadherin-SHP2 interaction ( Figure 3B ). In control TX-WT-GFP-transfected cells, low levels of VEcadherin-SHP2 interaction were observed as expected. In contrast, Y378A-GFP-transfected cells showed a 2-fold increased interaction between VE-cadherin and SHP2. These data demonstrate that TXNIP binding to SHP2 is regulated by the PPxY domain (AA375-378).
To demonstrate the functional mechanism by which TXNIP-SHP2 binding regulates Src activation, we performed a rescue experiment. We cotransfected cells with control or TXNIP siRNA, and then expressed TX-WT-GFP or Y378A-GFP plasmids, to rescue the activation of Src. When TX-WT-GFP was expressed, Src pY416 was low, but when Y378A-GFP was expressed, a 3.5-fold increase of Src pY416 was observed. When Y378A-GFP was expressed, Src pY416 was increased significantly similar to transfection with control siRNA as shown in Figure 3C . These data suggest that Y378A outcompetes endogenous TX-WT.
The in vivo data (Figure 1 and Online Figure I) suggest that s-flow promotes the VE-cadherin-SHP2 interaction based on the high levels of Src pY416. To show further the role of TXNIP in regulating VE-cadherin-SHP2 interaction, we exposed HUVEC to s-or d-flow conditions. There was a significant 3.5-fold increase in VE-cadherin-SHP2 interaction when s-flow was applied to HUVEC compared with d-flow samples (Online Figure VIII; P<0.05 ). To provide further evidence that TXNIP regulates SHP2 function, we measured SHP2 localization in control siRNA-or TXNIP siRNA-transfected cells by confocal microscopy (Online Figure VIII) . In control siRNA cells, SHP2 was found mainly in perinuclear and nuclear regions (Online Figure VIII) . In contrast, in TXNIP siRNAtransfected cells, SHP2 was excluded from the nucleus and was more evenly distributed throughout the cell (Online Figure VIII) .
Finally, to prove this mechanism, we measured CSK activation (serine 364 phosphorylation) under s-flow or d-flow conditions. Under s-flow conditions, CSK activation was low, consistent with low TXNIP expression and high Src activity. In contrast, under d-flow conditions, CSK activation was high, consistent with high TXNIP levels and low Src activity (Figure 4 ). To confirm this observation, we also transfected HUVEC with control or TXNIP siRNA. In control siRNA-transfected cells, a basal level of active CSK was observed, whereas in TXNIP siRNA-transfected cells, a 60% reduction in active CSK was observed (Online Figure IX) .
These data confirm our hypothesis that TXNIP regulates Src activation through indirect regulation of CSK inhibition by SHP2. Specifically, TXNIP regulates SHP2 subcellular recruitment to VE-cadherin to dephosphorylate and inhibit CSK.
TXNIP Acts as a Negative Regulator of Src and Stress Fibers Formation In Vitro
Because Src activity is important for F-actin stress fiber homeostasis, 35 we determined the role of TXNIP in stress fiber formation. We transfected HUVEC with control or TXNIP siRNA to evaluate Src activation state (pY416) and F-actin fibers (rhodamine-phalloidin fluorescence). Cells transfected with control siRNA had a low amount of stress fibers under baseline conditions that was consistent with low Src activation ( Figure 5A-5C ). In contrast, after transfection of TXNIP siRNA, stress fibers formed spontaneously that correlated with increased Src activation at the periphery of the cells and in cytosolic structures ( Figure 5D-5F ). Active Src localized with stress fibers, suggesting a link between reduced TXNIP expression and Src regulation of F-actin stress fibers ( Figure 5F ).
Flow Regulates TXNIP Expression and F-Actin Stress Fiber In Vitro and In Vivo
To study the physiological relevance of these observations, we analyzed the relationship among s-flow or d-flow, TXNIP expression, and F-actin stress fiber formation. First, we performed en face staining for TXNIP in s-flow and d-flow regions of the aortic arch of WT animals ( Figure 6A -6F). Consistent with previous studies, 9 TXNIP expression was significantly suppressed in regions of s-flow (greater curvature; Figure 6A -6C) compared with d-flow regions (lesser curvature; Figure 6D-6F) . Interestingly, TXNIP expression in s-flow and d-flow regions inversely correlated with formation of F-actin stress fibers. These data suggest an important inhibitory effect of TXNIP on EC stress fiber formation ( Figure 6G-6I) . Measuring the correlation between TXNIP and F-actin fibers showed a clear inverse correlation between TXNIP expression and F-actin formation (Online Figure X) .
To confirm a role for TXNIP in the regulation of stress fibers, HUVEC were exposed to no flow, s-flow, or d-flow conditions and TXNIP and F-actin levels were measured using immunofluorescence. Under no flow conditions, there were few stress fibers, and TXNIP was localized to the nucleus as indicated by colocalization of TXNIP and 4',6-diamidino-2-phenylindole staining ( Figure 7A-7C ). After s-flow stimulation (12 dyn/ cm 2 , 24-hour), EC aligned in the direction of flow and were characterized by increased stress fibers, and TXNIP expression was decreased ( Figure 7D-7F) . In contrast, EC that were exposed to d-flow (2 dyn/cm 2 , 24-hour) demonstrated no cell alignment, low stress fibers, and significantly increased TXNIP expression in both nucleus and cytosol ( Figure 7G-7I ; quantification of these data presented in Online Figure XI) . These data confirm the inhibitory role TXNIP plays in stress fiber formation under different flow patterns.
Discussion
The major findings of this study are that TXNIP is a biomechanical regulator of Src activity that controls EC stress fibers formation. Based on both in vitro and in vivo studies, we propose that TXNIP regulates a SHP2-CSK-Src signaling cascade ( Figure 8 ). Under d-flow conditions, TXNIP expression is high and CSK is active, leading to increased Src Y527 phosphorylation and low Src activity. In contrast, s-flow reduces TXNIP-SHP2 interaction that leads to dephosphorylation of CSK, decreased Src Y527 phosphorylation, and activation of Src. Importantly, active Src was observed mainly in linear structures that appeared similar to stress fibers, as indicated with white arrows in Figure 1 . In EC, Src activation correlated with increased F-actin stress fibers formation both in vivo and in vitro. Physiologically, this model explains the presence of stress fibers in regions of s-flow and absence of stress fibers in regions of d-flow, as originally described by Kim et al. 36 Furthermore, stress fiber formation is likely to be important in diverse EC functions, such as migration, permeability and apoptosis, cell shape change and alignment, mechano-signal transduction, EC-cell junction, and EC structural and functional integrity. [37] [38] [39] [40] [41] [42] [43] [44] The present study further supports the role of TXNIP as an arrestin-like scaffold protein that coordinates cell-signaling mechanisms that occur in specific subcellular locations. Recently, we performed a sequence analysis of TXNIP and described several binding motifs that can facilitate TXNIP interaction with multiple proteins under different biological conditions. 32 Particularly important are the 4 SH3 and 2 PPxY motifs. The current article demonstrating the critical role for Y378 in the C-terminal PPxY is the first description of a functional TXNIP motif that interacts with SHP2. Future studies will describe the binding partners that mediate TXNIP localization to specific subcellular locations, such as nucleus, cytosol, and PM. 28, 45, 46 For example, we and others showed previously that PARP1 (poly-ADP-ribose polymerase 1) and thioredoxin regulate TXNIP localization. 47 Recently, we also showed that in response to VEGF receptor 2 activation, TXNIP translocates from the nucleus and interacts with Rab5 to regulate endocytosis and angiogenesis. 48 Our data show that TXNIP is a key regulator of Src activity, which is important in physiological and pathological cell functions. For example, under physiological conditions, when EC are exposed to s-flow, TXNIP expression is low. Therefore, Src activity is high because Src pY527 is low and pY416 is high, resulting in EC stress fiber formation. Other examples that the relationship between TXNIP expression and Src activity include both tumorogenesis and metabolism. Decreased expression of TXNIP was shown to result in spontaneous tumorigenesis in multiple tissue types, which is related to its role as growth arrest protein. 49 This is consistent with data that Src is a well-known oncogene, which is highly active in tumor cells. 50 In addition, tumor metastasis requires stress fiber rearrangement and loss of cell interaction with matrix, processes facilitated by decreased TXNIP expression. 51 In terms of metabolism, Src and TXNIP have been shown to play important roles in glucose metabolism, mitochondrial function, and cell death. 47, [52] [53] [54] [55] [56] [57] In summary, this is the first demonstration that a specific TXNIP subcellular motif (C-terminal PPxY) mediates a critical cell function, specifically the interaction with SHP2 and regulation of Src activity. Furthermore, these findings suggest that TXNIP may play a broader role in regulating Src activity in multiple cell types, particularly in response to oncogenic and inflammatory stimuli. 
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